ARTL

Q: What is the price of Artelo Biosciences (ARTL) today?

The current price of Artelo Biosciences (ARTL) is $ 6.40, representing a -61.35% gain over the past year. The stock began the year trading around $ 1.22 and is currently priced at $ 6.40. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Artelo Biosciences (ARTL) pay dividends?

Artelo Biosciences (ARTL) did not pay dividends over the past year.

Artelo Biosciences Inc.

Price

$ 6.40

return (12m)

-61.35%

p/e

-0.55

p/bv

-5.54

DIVIDEND YIELD

0.00%

ARTL price

ARTL

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ARTL

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

58.02%

3 months

50.23%

1 year

-61.35%

2 years

-77.50%

5 years

-98.28%

10 years

0.00%

Fundamentals ARTL

review the fundamentals of Artelo Biosciences shares

P/E

-0.55

Sector: -2.15 Industry: 0.38

P/S (PSR)

Sector: 1.92 Industry: 2.43

P/BV

-5.54

Sector: 2.10 Industry: 2.24

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

-460.00%

Sector: -25.33% Industry: -23.48%

ROE

1,014.17%

Sector: -29.65% Industry: -31.19%

ROIC

-364.84%

Sector: -418.66% Industry: -76.94%

NET MARGIN

0.00%

Sector: -27.82% Industry: -30.15%

GROSS MARGIN

0.00%

Sector: 44.91% Industry: 51.03%

OPERATING MARGIN

0.00%

Sector: -22.85% Industry: -26.89%

EV/EBITDA

-0.56

Sector: -0.40 Industry: 1.11

EV/EBIT

-0.56

Sector: -1.68 Industry: -0.22

PRICE-TO-ASSETS

2.51

Sector: 1.13 Industry: 1.20

BVPS

-1.27

Sector: 3.83 Industry: 5.09

EPS

-12.88

Sector: -0.89 Industry: -0.80

EQUITY-TO-ASSETS RATIO

-0.45

Sector: 0.44 Industry: 0.46

LIABILITIES / ASSETS

1.45

Sector: 0.46 Industry: 0.50

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

8.53%

Sector: - Industry: -

Fundamentals ARTL

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ARTL Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Artelo Biosciences

Artelo Biosciences Inc.

Average Investor10 user rating

4.0 (1 people)

United States

15 years

Founded: 2011

2015

Time since IPO - 11 years

5

Employees

Artelo Biosciences Inc. (United States) is listed on the Nasdaq and has a market capitalization of $7.04 Millions, with shareholders equity totaling $-1.27 Million.

The company employs approximately 5 people and operates in the Health sector, within the Pharmaceutical Products industry.

Over the past 12 months, Artelo Biosciences Inc. reported $- in revenue, generating net income of $-12.88 Millions.

Key financial metrics include a P/E ratio of -0.55, a price-to-book (P/B) ratio of -5.54, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ARTL.

Market cap

$ 7.04 Millions

Net worth

$ -1.27 Million

$ -1,270,000.00

Assets

$ 2.80 Millions

$ 2,800,000.00

Total Shares Outstanding

1.00 Million

1,000,000

Average Daily Trading Volume

$ 3.42 Millions

$ 3,418,003.11

Sector

Health

Industry

Pharmaceutical Products

ARTL

ARTL revenue and profits

Financial Results ARTL

DRAG THE FRAME TO SEE MORE DATA

ARTL cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 79.16 20,24% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 278.37 --13,14% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 37.27 --40,26% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 197.45 --30,67% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 510.27 53,37% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 959.08 31,90% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 155.47 58,82% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34